Genomic Valley Biotech Ltd — Important, 15-01-2026: Company Update

Genomic Valley Biotech's Board of Directors met and approved the financial results for the quarter and nine months ending December 31, 2025. Additionally, Mr. Ashok Kumar ceased his directorship, effective immediately. This change occurred because he did not complete KYC requirements, leading to his cessation as a Director and member of all company committees under Section 167 of the Companies Act, 2013. This update provides clarity on the company's latest financial performance and a significant change in its governance structure.